Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Disposition and Metabolism of Cetrorelix, A Potent Luteinizing Hormone-Releasing Hormone Antagonist, in Rats and Dogs

Martin Schwahn, Hubert Schupke, Antje Gasparic, Dorothee Krone, Gernot Peter, Roland Hempel, Thomas Kronbach, Mathias Locher, Wolfgang Jahn and Jürgen Engel
Drug Metabolism and Disposition January 2000, 28 (1) 10-20;
Martin Schwahn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hubert Schupke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antje Gasparic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dorothee Krone
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gernot Peter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland Hempel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Kronbach
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathias Locher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Jahn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jürgen Engel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Disposition and metabolism of cetrorelix was studied in intact and bile duct-cannulated rats and dogs after s.c. injection. An s.c. dose of 0.1 mg/kg [14C]cetrorelix was rapidly and completely absorbed in rats. Tmax in plasma and most tissues was at 2 h. Radioactivity at the injection site in rats declined to 10% by 24 h. The extent of 14C absorption in rats calculated from excretion until 264 h was 94%. Exposure of the target organ pituitary gland was demonstrated with a time course similar to plasma but on a higher level. Rats excreted 69.6% of radioactivity via feces and 24.3% into urine. Excretion was nearly complete within 48 h. No enteral reabsorption was detected. In dogs tmax in plasma was 1.3 h.14C- and cetrorelix-plasma levels were similar until 24 h, indicating a negligible amount of metabolites. A dose of 1 mg/kg in dogs showed an increasing influence of a slow absorption phase (flip-flop). In dogs equal amounts of the 14C dose were found within 192 h in feces and urine, 46 and 48%, respectively. In urine of both species, only intact cetrorelix was detected. In bile and feces of both species qualitatively the same metabolites were found, characterized as truncated peptides of the parent decapeptide. The major metabolite occurring in bile of both species was the (1-7)heptapeptide. The amounts of the (1-4)tetrapeptide in feces of rats but not in that of dogs increase with time, suggesting additional degradation of the peptide in the gastrointestinal tract of rats by enteric metabolization.

Footnotes

  • Send reprint requests to: Dr. Martin Schwahn, Department of Biological Research Biochemistry, Corporate Research and Development, ASTA Medica Group, Weismüllerstraβe 45, D-60314 Frankfurt/Main, Germany. E-mail: martin.schwahn{at}astamedica.de

  • ↵1 Part of this work was presented at the 5th International ISSX Meeting, October 25–29, 1998, Cairns, Australia (Hempel et al., 1998).

  • Abbreviations used are::
    LH-RH
    luteinizing hormone-releasing hormone
    GI
    gastrointestinal
    PB
    protein binding
    LSC
    liquid scintillation counting
    SPHPLC
    semipreparative HPLC
    A/D
    adsorption/desorption chromatography
    MS
    mass spectrometry
    ESI-MS/MS
    electrospray mass spectroscopy
    ng-eq
    nanogram equivalents
    RIA
    radioimmunoassay
    • Received May 13, 1999.
    • Accepted September 8, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 28 (1)
Drug Metabolism and Disposition
Vol. 28, Issue 1
1 Jan 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Disposition and Metabolism of Cetrorelix, A Potent Luteinizing Hormone-Releasing Hormone Antagonist, in Rats and Dogs
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Disposition and Metabolism of Cetrorelix, A Potent Luteinizing Hormone-Releasing Hormone Antagonist, in Rats and Dogs

Martin Schwahn, Hubert Schupke, Antje Gasparic, Dorothee Krone, Gernot Peter, Roland Hempel, Thomas Kronbach, Mathias Locher, Wolfgang Jahn and Jürgen Engel
Drug Metabolism and Disposition January 1, 2000, 28 (1) 10-20;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Disposition and Metabolism of Cetrorelix, A Potent Luteinizing Hormone-Releasing Hormone Antagonist, in Rats and Dogs

Martin Schwahn, Hubert Schupke, Antje Gasparic, Dorothee Krone, Gernot Peter, Roland Hempel, Thomas Kronbach, Mathias Locher, Wolfgang Jahn and Jürgen Engel
Drug Metabolism and Disposition January 1, 2000, 28 (1) 10-20;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human ADME properties of abrocitinib
  • Impact of physiological microenvironments on HepaRG cells
  • New Dog, Cat, and Pig P450 2J Enzymes
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics